|
⚲
|
| Keyboard |
| Adaptive Biotechnologies Corp | |
|---|---|
| Ticker | ADPT |
| CIK # | 0001478320 |
| CUSIP | 00650F109 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 1551 Eastlake Avenue East Suite 200, Seattle, WA 98102 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Adaptive Biotechnologies Corp | 2015-05-11 | 195.1 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| Adaptive TCR Corp | 2011-06-02 | 5.8 M | Exemption: 506 · Remaining: $1,678,476 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001478320] | 10-K | |
| [0001478320] | 10-Q | |
| [0001478320] | 3 | |
| [0001478320] | 4 | |
| [0001478320] | 5 | |
| [0001478320] | 8-K | |
| [0001478320] | D | |
| [0001478320] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rubinstein Julie
Common Stock
|
2026-03-31 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-31 | Sell | 19,060 | $13.45 | 256,357 |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-31 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-30 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Common Stock
|
2026-03-30 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-30 | Sell | 19,060 | $12.63 | 240,728 |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-27 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Common Stock
|
2026-03-27 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-27 | Sell | 2,738 | $12.49 | 34,198 |
|
Rubinstein Julie
Common Stock
|
2026-03-27 | Sell | 16,322 | $13.48 | 220,021 |
|
Rubinstein Julie
Common Stock
|
2026-03-26 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-26 | Sell | 19,060 | $14.12 | 269,127 |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-26 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-25 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Common Stock
|
2026-03-25 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-25 | Sell | 19,060 | $14.27 | 271,986 |
|
Rubinstein Julie
Stock Option (right to buy) · derivative
|
2026-03-24 | Option exercise | 14,722 | $0.00 | |
|
Rubinstein Julie
Common Stock
|
2026-03-24 | Sell | 19,060 | $13.70 | 261,122 |
|
Rubinstein Julie
Common Stock
|
2026-03-24 | Option exercise | 14,722 | $7.27 | 107,029 |
|
Rubinstein Julie
Common Stock
|
2026-03-23 | Sell | 19,060 | $13.83 | 263,600 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 295 | 149,068,744 |
| 2025-12-31 | 284 | 145,178,796 |
| 2025-09-30 | 271 | 144,198,543 |
| 2025-06-30 | 242 | 148,574,986 |
| 2025-03-31 | 227 | 154,829,862 |
| 2024-12-31 | 208 | 142,787,196 |
| 2024-09-30 | 189 | 144,045,507 |
| 2024-06-30 | 178 | 149,632,220 |
| 2024-03-31 | 192 | 144,270,538 |
| 2023-12-31 | 203 | 144,093,240 |
| 2023-09-30 | 192 | 139,134,944 |
| 2023-06-30 | 212 | 134,772,050 |